Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Aiba

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Internal Medicine (Tokyo, Japan)|June 17, 2014
Pulmonary Nocardia nova infection after allogeneic hematopoietic stem cell transplantationHideaki Yamakawa, Masahiro Yoshida, Noriyuki Morikawa, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 23, 2016
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of JapanYoshifumi Baba, Hideo Baba, Sachiko Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 20, 2012
Complete response of esophageal small cell carcinoma amrubicin treatmentEijiro Nagasaki, Masami Yuda, Yuichiro Tanishima, et al.
Radiation Medicine|October 8, 2004
Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRIMitsuhiro Tozaki, Shinji Uno, Tadashi Kobayashi, et al.
Japanese Journal of Clinical Oncology|March 19, 2011
Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experienceNobuaki Dobashi, Noriko Usui, Shingo Yano, et al.
Anticancer Research|April 13, 2016
Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II StudyAkira Matsumoto, Katsunori Nishikawa, Masami Yuda, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancerYutaka Okawa, Katsuki Sugiyama, Keisuke Aiba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 2003
[Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report]Yasuhiro Arakawa, Nobuyuki Mizunuma, Keisuke Aiba, et al.
Leukemia & Lymphoma|February 28, 2015
Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawalYumiko Inui, Hiroshi Matsuoka, Kimikazu Yakushijin, et al.
Anti-Cancer Drugs|April 7, 2007
Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancerTakao Katsube, Kenji Ogawa, Wataru Ichikawa, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Internal Medicine (Tokyo, Japan)|June 17, 2014
Pulmonary Nocardia nova infection after allogeneic hematopoietic stem cell transplantationHideaki Yamakawa, Masahiro Yoshida, Noriyuki Morikawa, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 23, 2016
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of JapanYoshifumi Baba, Hideo Baba, Sachiko Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 20, 2012
Complete response of esophageal small cell carcinoma amrubicin treatmentEijiro Nagasaki, Masami Yuda, Yuichiro Tanishima, et al.
Radiation Medicine|October 8, 2004
Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRIMitsuhiro Tozaki, Shinji Uno, Tadashi Kobayashi, et al.
Japanese Journal of Clinical Oncology|March 19, 2011
Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experienceNobuaki Dobashi, Noriko Usui, Shingo Yano, et al.
Anticancer Research|April 13, 2016
Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II StudyAkira Matsumoto, Katsunori Nishikawa, Masami Yuda, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancerYutaka Okawa, Katsuki Sugiyama, Keisuke Aiba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 2003
[Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report]Yasuhiro Arakawa, Nobuyuki Mizunuma, Keisuke Aiba, et al.
Leukemia & Lymphoma|February 28, 2015
Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawalYumiko Inui, Hiroshi Matsuoka, Kimikazu Yakushijin, et al.
Anti-Cancer Drugs|April 7, 2007
Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancerTakao Katsube, Kenji Ogawa, Wataru Ichikawa, et al.
Pageof 8